These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
363 related items for PubMed ID: 24349054
1. No correlation between PNPLA3 rs738409 genotype and fatty liver and hepatic cirrhosis in Japanese patients with HCV. Nakamura M, Kanda T, Nakamoto S, Miyamura T, Jiang X, Wu S, Yokosuka O. PLoS One; 2013; 8(12):e81312. PubMed ID: 24349054 [Abstract] [Full Text] [Related]
2. The Impact of PNPLA3 rs738409 SNP on Liver Fibrosis Progression, Portal Hypertension and Hepatic Steatosis in HIV/HCV Coinfection. Scheiner B, Mandorfer M, Schwabl P, Payer BA, Bucsics T, Bota S, Aichelburg MC, Grabmeier-Pfistershammer K, Stättermayer A, Ferenci P, Trauner M, Peck-Radosavljevic M, Reiberger T. PLoS One; 2015; 10(11):e0143429. PubMed ID: 26599080 [Abstract] [Full Text] [Related]
3. The rs738409 polymorphism of the PNPLA3 gene is associated with hepatic steatosis and fibrosis in Brazilian patients with chronic hepatitis C. Manchiero C, Nunes AKDS, Magri MC, Dantas BP, Mazza CC, Barone AA, Tengan FM. BMC Infect Dis; 2017 Dec 19; 17(1):780. PubMed ID: 29258449 [Abstract] [Full Text] [Related]
4. Effect of PNPLA3 rs738409 variant (I148 M) on hepatic steatosis, necroinflammation, and fibrosis in Japanese patients with chronic hepatitis C. Yasui K, Kawaguchi T, Shima T, Mitsuyoshi H, Seki K, Sendo R, Mizuno M, Itoh Y, Matsuda F, Okanoue T. J Gastroenterol; 2015 Aug 19; 50(8):887-93. PubMed ID: 25543233 [Abstract] [Full Text] [Related]
5. Impact of patatin-like phospholipase-3 (rs738409 C>G) polymorphism on fibrosis progression and steatosis in chronic hepatitis C. Trépo E, Pradat P, Potthoff A, Momozawa Y, Quertinmont E, Gustot T, Lemmers A, Berthillon P, Amininejad L, Chevallier M, Schlué J, Kreipe H, Devière J, Manns M, Trépo C, Sninsky J, Wedemeyer H, Franchimont D, Moreno C. Hepatology; 2011 Jul 19; 54(1):60-9. PubMed ID: 21488075 [Abstract] [Full Text] [Related]
6. PNPLA3 rs738409 causes steatosis according to viral & IL28B genotypes in hepatitis C. Ampuero J, Del Campo JA, Rojas L, García-Lozano JR, Solá R, Andrade R, Pons JA, Navarro JM, Calleja JL, Buti M, González-Escribano MF, Forns X, Diago M, García-Samaniego J, Romero-Gómez M. Ann Hepatol; 2014 Jul 19; 13(4):356-63. PubMed ID: 24927606 [Abstract] [Full Text] [Related]
9. Impact of IL28B and PNPLA3 polymorphisms on treatment outcomes in patients infected with genotype 6 hepatitis C virus. Wong GL, Chan HL, Tse CH, Chan PO, Cheng JC, Cheng JS, Lau SH, Lee EK, Ma JM, Chan AW, Choi PC, Wong VW. J Gastroenterol Hepatol; 2015 Jun 19; 30(6):1040-8. PubMed ID: 25639146 [Abstract] [Full Text] [Related]
10. The influence of gene-chronic hepatitis C virus infection on hepatic fibrosis and steatosis. Magri MC, Manchiero C, Prata TVG, Nunes AKDS, Oliveira Junior JS, Dantas BP, Tengan FM. Diagn Microbiol Infect Dis; 2020 Jun 19; 97(2):115025. PubMed ID: 32147132 [Abstract] [Full Text] [Related]
11. Patatin-like phospholipase domain-containing 3 I148M polymorphism, steatosis, and liver damage in chronic hepatitis C. Valenti L, Rumi M, Galmozzi E, Aghemo A, Del Menico B, De Nicola S, Dongiovanni P, Maggioni M, Fracanzani AL, Rametta R, Colombo M, Fargion S. Hepatology; 2011 Mar 19; 53(3):791-9. PubMed ID: 21319195 [Abstract] [Full Text] [Related]
12. PNPLA3 rs738409 G allele carriers with genotype 1b HCV cirrhosis have lower viral load but develop liver failure at younger age. Senkerikova R, Frankova S, Jirsa M, Kreidlova M, Merta D, Neroldova M, Chmelova K, Spicak J, Sperl J. PLoS One; 2019 Mar 19; 14(9):e0222609. PubMed ID: 31527889 [Abstract] [Full Text] [Related]
14. PNPLA3 rs738409 Polymorphism Associated with Hepatic Steatosis and Advanced Fibrosis in Patients with Chronic Hepatitis C Virus: A Meta-Analysis. Fan JH, Xiang MQ, Li QL, Shi HT, Guo JJ. Gut Liver; 2016 May 23; 10(3):456-63. PubMed ID: 26419236 [Abstract] [Full Text] [Related]
16. Genetic polymorphism in cyclooxygenase-2 promoter affects hepatic inflammation and fibrosis in patients with chronic hepatitis C. Miyashita M, Ito T, Sakaki M, Kajiwara A, Nozawa H, Hiroishi K, Kobayashi M, Kumada H, Imawari M. J Viral Hepat; 2012 Sep 23; 19(9):608-14. PubMed ID: 22863264 [Abstract] [Full Text] [Related]